GC Genome Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	111,868	161,298	-	-	-	-
Enterprise Value	73,109	124,035	-	-	-	-
Last Close Price	4730.00	6820.00	-	-	-	-
PE Ratio	23.72	39.88	-	-	-	-
PS Ratio	3.48	5.12	-	-	-	-
PB Ratio	1.41	2.06	-	-	-	-
P/TBV Ratio	1.42	2.08	-	-	-	-
P/FCF Ratio	84.79	163.66	-	-	-	-
P/OCF Ratio	68.60	124.37	-	-	-	-
EV/Sales Ratio	2.27	3.93	-	-	-	-
EV/EBITDA Ratio	15.49	30.23	-	-	-	-
EV/EBIT Ratio	37.41	100.38	-	-	-	-
EV/FCF Ratio	55.41	125.85	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.14	0.47	0.40	0.74
Debt / EBITDA Ratio	0.94	0.98	2.35	3.18	-	-
Debt / FCF Ratio	2.95	4.08	94.54	-	-	-
Net Debt / Equity Ratio	-0.49	-0.46	-0.06	0.13	-0.26	-0.61
Net Debt / EBITDA Ratio	-9.30	-8.80	-0.93	0.84	16.39	224.25
Net Debt / FCF Ratio	-29.38	-36.63	-37.60	-0.77	1.25	3.96
Asset Turnover	0.49	0.50	0.62	0.60	0.53	0.44
Inventory Turnover	7.93	10.51	11.96	11.56	14.85	-
Quick Ratio	9.18	17.67	3.74	1.00	2.13	6.26
Current Ratio	9.80	18.59	4.27	1.12	2.32	6.42
Return on Equity (ROE)	8.11%	7.26%	-4.32%	-2.13%	-16.52%	1.56%
Return on Assets (ROA)	1.34%	1.23%	-1.85%	0.22%	-4.43%	-3.13%
Return on Invested Capital (ROIC)	3.10%	3.28%	-4.15%	0.67%	-24.07%	-34.01%
Return on Capital Employed (ROCE)	1.70%	1.50%	-3.30%	0.50%	-8.40%	-5.60%
Earnings Yield	4.08%	2.51%	-	-	-	-
FCF Yield	1.18%	0.61%	-	-	-	-
Buyback Yield / Dilution	-22.48%	-20.29%	0.66%	-13.53%	-0.97%	10.25%